What is Stephens's price target for ANIK?

Stephens's latest stated price target for Anika Therapeutics Inc. (ANIK) is $26, from its action on Oct 14, 2022.

What is Stephens's rating on ANIK?

Stephens rates ANIK Equal-Weight, a neutral rating, as of Oct 14, 2022.

When did Stephens last change its view on ANIK?

On Oct 14, 2022, Stephens resumes coverage at Equal-Weight, price target $26.

Stephens ANIK price target and rating history

Anika Therapeutics Inc. (ANIK) · Health Care

Stephens rates Anika Therapeutics Inc. (ANIK) Equal-Weight with a $26 price target, as of its latest action on Oct 14, 2022. It has published 4 rating actions on ANIK since November 2021, including 0 upgrades and 2 downgrades.

Current rating: Equal-Weight
Price target: $26
Median target, all firms: Too few
Actions on ANIK: 4

Stephens price target on ANIK

Stephens price target on ANIK, each point a stated target, November 2021 to October 2022.

Every Stephens rating on ANIK

Oct 14, 2022
ResumeStephens resumes coverage at Equal-Weight, price target $26
Mar 9, 2022
DowngradeStephens downgrades to Equal-Weight from Overweight
Mar 9, 2022
DowngradeStephens downgrades to Equal-Weight from Overweight, price target $35
Nov 16, 2021
InitiateStephens starts coverage at Overweight, price target $55

Questions about Stephens and ANIK

What is Stephens's price target for ANIK?: Stephens's latest stated price target for Anika Therapeutics Inc. (ANIK) is $26, from its action on Oct 14, 2022.
What is Stephens's rating on ANIK?: Stephens rates ANIK Equal-Weight, a neutral rating, as of Oct 14, 2022.
When did Stephens last change its view on ANIK?: On Oct 14, 2022, Stephens resumes coverage at Equal-Weight, price target $26.

More ANIK rating histories

Barrington Research5

All Stephens ratings ANIK news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.